How did the QSAR modelling assist in lowering the EC₅₀ of the lead compound being developed to treat people with cystic fibrosis who have the ∆508 CFTR mutation?

Question

How did the QSAR modelling assist in lowering the EC 50  of the lead compound being developed to treat people with cystic fibrosis who have the ∆508 CFTR mutation?

Answer

The QSAR modelling only produced a list of top hits that had lower EC 50  values than the initial VRT-715 lead compound

Answer

The QSAR modelling identified that having an -tBu group at position R4 in the compound was sufficient to lower the EC 50  of the compound, no matter what other chemical groups were chosen for the R6 & X positions

Answer

The QSAR modelling identified that the most crucial change to the VRT-715 compound was having the -tBu chemical group at the R4 & R6 positions in order to lower the EC 50  of the compound

Answer

The QSAR modelling determined important positions with the VRT-715 compound that impacted the EC 50  of the lead compound, before attempting to identify optimal combinations of chemical groups in these positions

Crowdly

How did the QSAR modelling assist in lowering the EC 50 of the lead compound be...

Want instant access to all verified answers on learning.monash.edu?